Alberta tender · NOA
University of Alberta - Notice of Award - AP 20-202 Adjuvant Formulation (40µG/ml SLA; 4% Squalene oil; 0.6ml fill volume) for formulation of HCV Vaccine
Reference number: noa 2025-0025
Issuing organization: University of Alberta
Location: ["Alberta"]
Published: 2025-02-03
Tender details
University of Alberta has issued a tender in Alberta for a clinical-grade adjuvant formulation for HCV vaccine research. The product will be used in Phase I vaccine development and must support the department’s immune-response studies.